Aldesleukin Recruiting Phase 1 Trials for Metastatic Renal Cell Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02926053TIL Therapy for Metastatic Renal Cell Carcinoma